By Bill Current, Founder of the Current Consulting Group Did you know the Drug Enforcement Administration’s (DEA) mission is to “enforce the controlled substances laws and regulations of the United States… and support non-enforcement programs aimed at reducing the...
Advocacy
Featured posts
All posts
Legislative Update 7/2024
By Tim Monahan NDASA is actively engaged in seeking a safety carve-out to protect public safety through continued testing for THC should the U.S. Department of Justice succeed in forcing the Drug Enforcement Administration to reschedule marijuana, against the findings...
Marijuana legalization, the DEA and harmful, unintended consequences
By Bill Current, Founder of the Current Consulting Group It’s been said that elections have consequences, including unintended consequences that can be harmful, nonetheless. The Drug Enforcement Administration (DEA), at President Biden’s direction, intends to...
NDASA’s public comments on the proposed rescheduling of marijuana – Part 1
The Honorable Merrick B....
How to provide comment for the DEA’s Notice of Proposed Rulemaking (NPRM) regarding the rescheduling of marijuana
Make your voice heard! You can have an impact on the U.S. Drug Enforcement Administration’s proposal to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act by providing comment to the NPRM. The deadline for submitting...
National Drug & Alcohol Screening Association urges protection of transportation safety amid marijuana rescheduling debate
Rescheduling marijuana to Schedule III will prevent the U.S. Department of Transportation from prohibiting active use for those in transportation safety positions. Without a safety carveout - or a clear plan to prevent this unintended consequence, the traveling public...
Make Your Voice Heard: Submit comments to DOT by April 5
UPDATED WITH NEW DEADLINE The public comment period for the Federal Aviation Administration's Foreign Repair Station Notice of Proposed Rulemaking closes on April 5, 2024. (This is an extension from the initial deadline of 2.5.24). Have you shared your thoughts with...
NDASA’s Public Comments on the Proposed Addition of fentanyl to the Federal Workplace Drug Testing Panels
NDASA recently submitted public comments on behalf of its members in the drug and alcohol testing industry to the Department of Health and Human Services regarding its proposed amendment to the Mandatory Guidelines for Federal Workplace Drug Testing Programs to...
NDASA responds to SAMHSA proposed rules for Oral Fluid Testing in federal workplaces
In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On June 1, NDASA submitted...
NDASA’s response to proposed guidelines for Oral Fluid Testing and other changes to 49 CFR Part 40
In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On April 20, NDASA...